Past EventBioProcess International USA Conference & Exhibition, September 21-25
More than 20 leading biopharmaceutical companies announced yesterday the creation of an estimated $1 billion fund to help support the pipeline for new antibiotic treatments. The AMR Action Fund was launched as antimicrobial resistance, or AMR, continues to grow and take lives. In a statement, BIO President and CEO Dr. Michelle McMurry-Heath said, “Even as the world’s scientists work tirelessly to fight COVID-19, we must not ease up on our battle against antimicrobial resistance.”
To Top
